title: Celgene eyes 'inverse vaccines' in Anokion and Delinia deals.
authors.forename: Cormac
authors.initials: C
authors.lastname: Sheridan
mesh_terms: D001327:Autoimmune Diseases / Q000188:drug therapy*; D004345:Drug Industry; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects* / Q000276:immunology; D007155:Immunologic Factors / Q000627:therapeutic use*; D014612:Vaccines / Q000627:therapeutic use
chemical_list: D007155:Immunologic Factors; D014612:Vaccines